These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28735048)

  • 1. Emergence of different Acinetobacter baumannii clones in a Croatian hospital and correlation with antibiotic susceptibility.
    Ladavac R; Bedenić B; Vranić-Ladavac M; Barišić N; Karčić N; Pompe K; Ferenčić A; Stojanović A; Seifert H; Katić S; Higgins PG
    J Glob Antimicrob Resist; 2017 Sep; 10():213-218. PubMed ID: 28735048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of Carbapenem-Hydrolyzing Oxacillinases in Acinetobacter baumannii in Children from Croatia.
    Lukić-Grlić A; Kos M; Žižek M; Luxner J; Grisold A; Zarfel G; Bedenić B
    Chemotherapy; 2019; 64(4):167-172. PubMed ID: 31707391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.
    Correa A; Del Campo R; Escandón-Vargas K; Perenguez M; Rodríguez-Baños M; Hernández-Gómez C; Pallares C; Perez F; Arias CA; Cantón R; Villegas MV
    Microb Drug Resist; 2018; 24(1):48-54. PubMed ID: 28570118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-β-lactamase genes are widespread among hospitalized burn patients in Tehran.
    Mahdian S; Sadeghifard N; Pakzad I; Ghanbari F; Soroush S; Azimi L; Rastegar-Lari A; Giannouli M; Taherikalani M
    J Infect Public Health; 2015; 8(6):533-42. PubMed ID: 26111484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
    Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
    Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
    Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
    J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
    Lowings M; Ehlers MM; Dreyer AW; Kock MM
    BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.
    Rieber H; Frontzek A; Pfeifer Y
    Microb Drug Resist; 2017 Jan; 23(1):25-31. PubMed ID: 27093111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study.
    Wu W; He Y; Lu J; Lu Y; Wu J; Liu Y
    PLoS One; 2015; 10(9):e0137174. PubMed ID: 26340666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical and sewage isolates of Acinetobacter baumannii from two long-term care facilities in Zagreb; mechanisms and routes of spread.
    Bedenić B; Siroglavić M; Slade M; Šijak D; Dekić S; Musić MŠ; Godan-Hauptman A; Hrenović J
    Arch Microbiol; 2020 Mar; 202(2):361-368. PubMed ID: 31667533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of Three Different Methods in Investigating the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates].
    Uluçam Atay G; Bayramoğlu G; Tosun İ; Ünsal Ü
    Mikrobiyol Bul; 2024 Apr; 58(2):97-112. PubMed ID: 38676579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of carbapenem non-susceptible multidrug resistant Acinetobacter baumannii strains of clonal complexes 103(B) and 92(B) harboring OXA-type carbapenemases and metallo-β-lactamases in Southern India.
    Saranathan R; Vasanth V; Vasanth T; Shabareesh PR; Shashikala P; Devi CS; Kalaivani R; Asir J; Sudhakar P; Prashanth K
    Microbiol Immunol; 2015 May; 59(5):277-84. PubMed ID: 25726848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transferability of blaOXA-23 gene in multidrug-resistant Acinetobacter baumannii isolates from Saudi Arabia and Egypt.
    Lopes BS; Al-Agamy MH; Ismail MA; Shibl AM; Al-Qahtani AA; Al-Ahdal MN; Forbes KJ
    Int J Med Microbiol; 2015 Sep; 305(6):581-8. PubMed ID: 26253451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of OXA-23 and OXA-58 Carbapenemases Coexpressed in Clinical Isolates of Acinetobacter baumannii in Tunisia.
    Mathlouthi N; Ben Lamine Y; Somai R; Bouhalila-Besbes S; Bakour S; Rolain JM; Chouchani C
    Microb Drug Resist; 2018 Mar; 24(2):136-141. PubMed ID: 28691891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
    Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
    J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing imipenem resistance and dissemination of the ISAba1-associated blaOXA-23 gene among Acinetobacter baumannii isolates in an intensive care unit.
    He C; Xie Y; Zhang L; Kang M; Tao C; Chen Z; Lu X; Guo L; Xiao Y; Duo L; Fan H
    J Med Microbiol; 2011 Mar; 60(Pt 3):337-341. PubMed ID: 21127157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.